Cypress Capital Management (Wyoming)’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Hold
0
-$3K 377
2018
Q2
Hold
0
311

Cypress Capital Management (Wyoming)'s AMPE Position: Q2 2026 in Review

Cypress Capital Management (Wyoming) sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2026, closing a stake of 440 shares — an estimated $67 sold.

Cypress Capital Management (Wyoming) first reported a position in AMPE in Q4 2016 and held it in 35 quarters. The position peaked at $708K in Q2 2018. 0 funds tracked by Wall St. Rank hold AMPE as of Q2 2026.

  • Cypress Capital Management (Wyoming) reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2026 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 440 Ampio Pharmaceuticals Inc. shares in Q2 2026, an estimated $67.
  • Cypress Capital Management (Wyoming) first reported a position in Ampio Pharmaceuticals Inc. in Q4 2016 and held it in 35 quarters.
  • Cypress Capital Management (Wyoming)'s Ampio Pharmaceuticals Inc. position peaked at $708K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.